Financial Performance - The company reported total revenue of 2.386 billion yuan for the first half of 2025, a year-on-year decrease of 2.28% [1] - The net profit attributable to shareholders was 238 million yuan, down 8.02% year-on-year [1] - In Q2, total revenue was 1.195 billion yuan, reflecting a year-on-year decline of 7.33% [1] - The net profit for Q2 was 115 million yuan, a decrease of 15.66% year-on-year [1] - The gross margin was 26.82%, an increase of 1.54% year-on-year, while the net margin was 10.03%, down 5.38% year-on-year [1] Financial Ratios and Metrics - The company's accounts receivable reached 199.31% of the latest annual net profit, indicating a significant amount of receivables [1][2] - The total of selling, administrative, and financial expenses was 246 million yuan, accounting for 10.29% of revenue, which is a year-on-year increase of 12.77% [1] - Earnings per share (EPS) was 0.54 yuan, down 6.9% year-on-year [1] - The company reported a return on invested capital (ROIC) of 13.85% last year, with a historical median ROIC of 16.1% since its listing [2] - The estimated dividend yield is 5.03% [2] Cash Flow and Assets - Operating cash flow per share was 0.29 yuan, a significant decrease of 49.4% year-on-year [1] - The net asset value per share was 7.44 yuan, reflecting a year-on-year increase of 6.4% [1]

Group 1 - The company is holding its first extraordinary general meeting of shareholders in 2025 on September 15, 2025, at 14:30 [3] - The meeting will take place at the conference room of the company's office located at 69 Tianfeng Road, Jimei District, Xiamen [3] - The agenda includes the announcement of the meeting's commencement, reporting attendance, and the election of vote counters [4] Group 2 - Shareholders or their proxies must register before the meeting and present valid identification [2] - The meeting will adopt a named voting method for the resolutions, and shareholders can express their voting intentions as "agree," "disagree," or "abstain" [2][3] - The first resolution to be discussed is the amendment of the company's articles of association and adjustments to the organizational structure [4]

Meeting Information - The first extraordinary general meeting of 2025 will be held on September 15, 2025, at 14:30 [1] - The meeting will take place at the conference room of the office building located at 69 Tianfeng Road, Jimei District, Xiamen [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's online voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts for the same category of shares [2][3] - Duplicate voting through different accounts will be counted based on the first vote cast [4] Attendance Requirements - Shareholders registered by the close of trading on September 8, 2025, are eligible to attend the meeting [5] - Personal shareholders must present valid identification and stock account cards, while corporate shareholders must provide relevant documentation [5] - Remote shareholders can register via fax, mail, or email [5] Other Information - The company has provided contact details for inquiries regarding the meeting, including a phone number and email address [6]

Meeting Overview - The third meeting of the board of directors of Xiamen Jianlin Health Home Co., Ltd. was held on August 28, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2]. Resolutions Passed - The board approved the "2025 Semi-Annual Report" and its summary, which had been reviewed and approved by the audit committee [2]. - The board also approved the "Special Report on the Storage and Actual Use of Raised Funds for the First Half of 2025," which was similarly disclosed on the Shanghai Stock Exchange [2]. - A resolution was passed to amend the company's articles of association and adjust the organizational structure, aiming to enhance corporate governance in line with the latest regulations [3]. Organizational Changes - Following the amendments, the "Shareholders' Meeting" will be renamed to "Shareholders' Assembly," and the supervisory board will be dissolved, with its powers transferred to the audit committee of the board [3]. - The nomination committee and the remuneration and assessment committee of the board will be merged into a single "Nomination and Remuneration Committee," with specific members appointed [3]. Upcoming Events - The company plans to hold its first extraordinary general meeting of 2025 on September 15, 2025, with details disclosed on the Shanghai Stock Exchange [5].

Meeting Overview - The third meeting of the Supervisory Board of Xiamen Jianlin Health Home Co., Ltd. was held on August 28, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1]. Resolutions Passed - The Supervisory Board approved the company's 2025 semi-annual report and its summary, affirming that the report's preparation and review processes complied with relevant laws, regulations, and internal management systems, accurately reflecting the company's operational and financial status [1][2]. - The Supervisory Board also approved the special report on the storage and actual use of raised funds for the first half of 2025, with the same unanimous voting outcome of 3 votes in favor and no votes against or abstentions [2].

Group 1 - The company reported a revenue of 2,386,484,624.83 yuan for the first half of 2025, representing a year-on-year decrease of 2.28% [1] - The net profit attributable to shareholders of the listed company was 238,239,355.39 yuan, showing a year-on-year decline of 8.02% [1]

Group 1 - The company Jianlin Home (603408.SH) reported a total operating revenue of 2.386 billion yuan for the first half of 2025, representing a year-on-year decrease of 2.28% [1] - The net profit attributable to shareholders of the parent company was 238 million yuan, down 8.02% year-on-year [1] - The basic earnings per share were 0.54 yuan [1]

厦门建霖健康家居股份有限公司 二〇二五年八月 0 厦门建霖健康家居股份有限公司 独立董事工作制度 第一章 总则 第一条 为了促进厦门建霖健康家居股份有限公司（以下简称"公司"）的规 范运作，维护公司整体利益，保障全体股东特别是中小股东的合法权益不受损害， 根据《中华人民共和国公司法》《中华人民共和国证券法》等法律、行政法规、规 范性文件和《厦门建霖健康家居股份有限公司章程》（以下简称《公司章程》）、中 国证券监督管理委员会（以下简称"中国证监会"）《上市公司独立董事管理办法》 等规定，制定本制度。 第二章 一般规定 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及公司主 要股东、实际控制人不存在直接或者间接利害关系，或者其他可能妨碍其进行独 立客观判断的关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或 者个人的影响。 独立董事工作制度 公司应当为独立董事依法履职提供必要保障。 第三条 独立董事对公司及全体股东负有忠实与勤勉义务，应当按照法律、行 政法规、中国证监会规定、上海证券交易所业务规则和《公司章程》的规定，认 真履行职责，在董事会中发挥参与决策、监督制衡、专 ...

厦门建霖健康家居股份有限公司 累积投票制实施细则 二〇二五年八月 厦门建霖健康家居股份有限公司 累积投票制实施细则 第一条 为维护中小股东的利益，完善公司法人治理结构，规范公司选举董 事行为，根据中国证监会《上市公司治理规则》《厦门建霖健康家居股份有限公 司章程》（以下简称《公司章程》）及其他有关规定，特制定本实施细则。 第六条 适用累积投票制选举公司董事的具体表决办法如下： （一）为确保独立董事当选人数符合《公司章程》的规定，独立董事与非独 立董事的选举实行分开投票方式。 具体操作如下： 选举独立董事时，每位股东有权取得的投票权数等于其所持有的股份乘以其 有权选出的独立董事人数的乘积数，该票数只能投向独立董事候选人。 选举非独立董事时，每位股东有权取得的投票权数等于其所持有的股份数乘 以他有权选出的非独立董事人数的乘积数，该票数只能投向非独立董事候选人。 （二）累积投票制的票数计算法 1、每位股东持有的有表决权的股份数乘以本次股东会选举董事人数之积， 即为该股东本次累积表决票数。 2、公司董事会秘书应当在累积投票表决前，宣布每位股东的累积表决票数， 任何股东、公司独立董事、本次股东会监票人或见证律师对宣布结 ...

厦门建霖健康家居股份有限公司 董事会议事规则 二〇二五年八月 厦门建霖健康家居股份有限公司 董事会议事规则 第一章 总则 第一条 为明确公司董事会的职责权限，规范公司董事会的议事方式和决策 程序，促使公司董事和董事会有效地履行其职责，提高公司董事会规范运作和科 学决策水平，根据《中华人民共和国公司法》《中华人民共和国证券法》以及《厦 门建霖健康家居股份有限公司章程》（以下简称《公司章程》）等有关规定，制 定本规则。 第二条 公司设立董事会秘书，对公司和董事会负责，并设立由董事会秘书 负责管理的董事会办公室，处理董事会日常事务。 董事会秘书或者证券事务代表负责保管董事会印章。 第三条 董事会会议分为定期会议和临时会议，每年应当至少召开两次会议。 第二章 董事会的召集 第四条 在发出召开董事会定期会议的通知前，董事会秘书应当充分征求各 董事的意见，初步形成会议提案后交董事长拟定。董事长在拟定提案前，应当视 需要征求高级管理人员的意见。 第五条 有下列情形之一的，董事会应当召开临时会议： （一）代表十分之一以上表决权的股东提议时； （二）三分之一以上董事联名提议时； （三）审计委员会提议时； （四）董事长认为必要时 ...